Cigarette Smoking and Colorectal Cancer Risk by Molecularly Defined Subtypes

Abstract

BackgroundCigarette smoking is an established risk factor for colorectal cancer. Because colorectal carcinogenesis is a heterogeneous process, we investigated whether cigarette smoking is differentially associated with molecularly defined subtypes of colorectal cancer. MethodsWe evaluated associations between smoking and incident colorectal cancer, overall and by microsatellite instability (MSI) phenotype (MSI-high vs MSI-low or microsatellite stable), CpG island methylator phenotype (CIMP positive or CIMP negative), and BRAF mutation status (BRAF mutation positive or BRAF mutation negative), among 37 399 participants in a population-based cohort study (the Iowa Women's Health Study). Cigarette smoking (and other exposures) was assessed by self-report at baseline in 1986, including smoking status (never and ever [former or current]), age at initiation, total duration, average number of cigarettes smoked per day, cumulative pack-years, and induction period. Vital status and state of residence were determined by mailed follow-up questionnaires in 1987, 1989, 1992, and 1997 and by linkage to Iowa death certificate records. Nonrespondents were checked via the National Death Index to identify descendants. Participants with newly diagnosed (ie, incident) colorectal cancer were identified through annual linkage with the Iowa Cancer Registry. Archived paraffin-embedded tumor tissue specimens were obtained for 555 patients with colorectal cancer who were diagnosed from January 1, 1986, through December 31, 2002, and MSI status, CIMP status, and BRAF status were determined. Multivariable Cox regression models were fit to estimate relative risks (RRs) and 95% confidence intervals (CIs). ResultsEver-smokers were at moderately increased risk for incident colorectal cancer (RR = 1.19, 95% CI = 1.05 to 1.35) compared with never-smokers. Higher risk estimates were observed for current smokers with MSI-high tumors (RR = 1.99, 95% CI = 1.26 to 3.14), CIMP-positive tumors (RR = 1.88, 95% CI = 1.22 to 2.90), and BRAF mutationpositive tumors (RR = 1.92, 95% CI = 1.22 to 3.02). Other smoking-related variables (ie, age at initiation, total duration, average number of cigarettes smoked per day, cumulative pack-years, and induction period) were also associated with MSI-high, CIMP-positive, and BRAF mutation-positive tumor subtypes. Conversely, cigarette smoking status (ever vs never) was not associated with the MSI-low or microsatellite stable (RR = 1.00, 95% CI = 0.79 to 1.25), CIMP-negative (RR = 1.02, 95% CI = 0.81 to 1.30), or BRAF mutation-negative subtypes (RR = 1.00, 95% CI = 0.65 to 1.27). ConclusionsIn this prospective study of older women, cigarette smoking was associated with the MSI-high, CIMP-positive, and BRAF mutation-positive colorectal cancer subtypes, which indicates that epigenetic modification may be functionally involved in smoking-related colorectal carcinogenesis. Risk Factor AssessmentCigarette smoking patterns among IWHS participants were comprehensively ascertained at baseline in 1986, including smoking statu...

Simple Clinical Risk Score Identifies Patients with Serrated Polyps in Routine Practice

“…The strong association between current smoking and presence of 1 LPD SP is in agreement with existing literature data (18-21, 37, 38, 42). Of note, (current) smoking has been also associated with proximal colorectal cancers, showing extensive DNA methylation, BRAF mutation, and microsatellite instability (43,44). These shared molecular features in serrated polyps and colorectal cancers arising through the serrated neoplastic pathway (39,(45)(46)(47) may imply that smoking has an important role in the serrated carcinogenesis.…”

Establishment of the Cancer Prevention Study II Nutrition Cohort Colorectal Tissue Repository

“…The methods used to establish this repository are described in detail to motivate and inform future collections of tissue materials in other epidemiologic studies. With tissue samples accrued thus far from 882 participants diagnosed with colon or rectal cancer, the CPS-II colorectal tissue repository is on par with or larger than other tissue collections from comparable prospective cohort studies, including the Nurses' Health Study and Health Professionals Follow-up Study (21)(22)(23), European Prospective Investigation into Cancer and Nutrition (EPIC) (24), the Iowa Women's Health Study (8,25), the Melbourne Collaborative Cohort Study (6,26), the Netherlands Cohort Study (6), and the Northern Sweden Health and Disease Study (27).…”

“…Recent findings from MPE studies suggest that associations of obesity and smoking with colorectal cancer risk differ by tumor MSI or CIMP (4)(5)(6)(7)(8). Motivated, in part, by these findings, we sought to establish a repository of colorectal tissue specimens from participants enrolled in the Cancer Prevention Study-II (CPS-II) Nutrition Cohort.…”

The CpG Island Methylator Phenotype: What's in a Name?

“…Although CIMP has been associated with environmental and lifestyle factors (3,(42)(43)(44)(45)(46)(47)(48), the molecular basis for CIMP is only beginning to be explored. The first clues came from two studies showing that glioblastomas with a hypermethylator phenotype are associated with somatic mutations in isocitrate dehydrogenase-1 (IDH1; refs.…”